Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 33008 | 99 | 29.4 | 85% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1608 | 6531 | DOLASTATIN 10//DIDEMNIN B//CYCLOLINOPEPTIDE A |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SANSALVAMIDE A | Author keyword | 26 | 87% | 13% | 13 |
| 2 | URUKTHAPELSTATIN A | Author keyword | 6 | 100% | 4% | 4 |
| 3 | PL EXPT GENOM | Address | 2 | 43% | 3% | 3 |
| 4 | SANGUINAMIDE B | Author keyword | 1 | 100% | 2% | 2 |
| 5 | MACROCYCLIC PEPTIDES | Author keyword | 1 | 25% | 4% | 4 |
| 6 | N METHYLATED AMINO ACIDS | Author keyword | 1 | 50% | 1% | 1 |
| 7 | SILICON LINKER | Author keyword | 1 | 50% | 1% | 1 |
| 8 | SP2 0 MYELOMA CELL | Author keyword | 1 | 50% | 1% | 1 |
| 9 | HEBEI PROV MOL CHEM DRUG | Address | 0 | 20% | 2% | 2 |
| 10 | CHEM BIOL TEAM | Address | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SANSALVAMIDE A | 26 | 87% | 13% | 13 | Search SANSALVAMIDE+A | Search SANSALVAMIDE+A |
| 2 | URUKTHAPELSTATIN A | 6 | 100% | 4% | 4 | Search URUKTHAPELSTATIN+A | Search URUKTHAPELSTATIN+A |
| 3 | SANGUINAMIDE B | 1 | 100% | 2% | 2 | Search SANGUINAMIDE+B | Search SANGUINAMIDE+B |
| 4 | MACROCYCLIC PEPTIDES | 1 | 25% | 4% | 4 | Search MACROCYCLIC+PEPTIDES | Search MACROCYCLIC+PEPTIDES |
| 5 | N METHYLATED AMINO ACIDS | 1 | 50% | 1% | 1 | Search N+METHYLATED+AMINO+ACIDS | Search N+METHYLATED+AMINO+ACIDS |
| 6 | SILICON LINKER | 1 | 50% | 1% | 1 | Search SILICON+LINKER | Search SILICON+LINKER |
| 7 | SP2 0 MYELOMA CELL | 1 | 50% | 1% | 1 | Search SP2+0+MYELOMA+CELL | Search SP2+0+MYELOMA+CELL |
| 8 | TETRAHYDROANTHRAQUINONE | 0 | 33% | 1% | 1 | Search TETRAHYDROANTHRAQUINONE | Search TETRAHYDROANTHRAQUINONE |
| 9 | THERMOACTINOMYCES | 0 | 14% | 2% | 2 | Search THERMOACTINOMYCES | Search THERMOACTINOMYCES |
| 10 | CANCER CELL CYTOTOXICITY | 0 | 17% | 1% | 1 | Search CANCER+CELL+CYTOTOXICITY | Search CANCER+CELL+CYTOTOXICITY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SANSALVAMIDE A DERIVATIVES | 30 | 84% | 16% | 16 |
| 2 | SANSALVAMIDE | 25 | 70% | 21% | 21 |
| 3 | N METHYLSANSALVAMIDE | 15 | 77% | 10% | 10 |
| 4 | TRAP HOLLIDAY JUNCTIONS | 9 | 83% | 5% | 5 |
| 5 | GENUS FUSARIUM | 6 | 38% | 13% | 13 |
| 6 | MECHERCHARIMYCES ASPOROPHORIGENENS YM11 542 | 4 | 67% | 4% | 4 |
| 7 | MARINE FUNGUS | 4 | 28% | 11% | 11 |
| 8 | CYTOTOXIC SUBSTANCE | 3 | 100% | 3% | 3 |
| 9 | URUKTHAPELSTATIN A | 3 | 100% | 3% | 3 |
| 10 | CYTOTOXIC CYCLIC DEPSIPEPTIDE | 3 | 30% | 9% | 9 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Natural Products and their Analogues as Efficient Anticancer Drugs | 2009 | 24 | 83 | 11% |
| Conformationally based design of macrocycles as antitumor agents | 2008 | 4 | 49 | 18% |
| Predicting the unpredictable: Recent structure-activity studies on peptide-based macrocycles | 2015 | 0 | 106 | 19% |
| N-methylated cyclic pentaalanine peptides as template structures | 2006 | 47 | 89 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PL EXPT GENOM | 2 | 43% | 3.0% | 3 |
| 2 | HEBEI PROV MOL CHEM DRUG | 0 | 20% | 2.0% | 2 |
| 3 | CHEM BIOL TEAM | 0 | 33% | 1.0% | 1 |
| 4 | FIORGEN | 0 | 20% | 1.0% | 1 |
| 5 | QUIM METODOL ORGAN SINTET | 0 | 13% | 1.0% | 1 |
| 6 | BIOMOL STRUCT MODELLING GRP | 0 | 10% | 1.0% | 1 |
| 7 | CHEM LIF PROC | 0 | 100% | 1.0% | 1 |
| 8 | MED EXPLORATORY CHEM | 0 | 100% | 1.0% | 1 |
| 9 | UMR 5257UM2UM1 | 0 | 100% | 1.0% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000228058 | BEAUVERICIN//ENNIATINS//FUSAPROLIFERIN |
| 2 | 0.0000187404 | OXAZOLES//OXAZOLE//DIAZONAMIDE A |
| 3 | 0.0000176220 | HSP90//GELDANAMYCIN//HSP90 INHIBITORS |
| 4 | 0.0000153937 | DOLASTATIN 10//DIDEMNIN B//TZT 1027 |
| 5 | 0.0000106912 | CYCLOLINOPEPTIDE A//VACCARIA SEGETALIS//CYCLOLINOPEPTIDE |
| 6 | 0.0000100637 | BU 4664L//ORG INFECT CONTROL SCI//DIAZEPINOMICIN |
| 7 | 0.0000094882 | PEPTOIDS//PEPTOID//PROTEIN MIMETIC MATERIALS |
| 8 | 0.0000088513 | HEXAFLUOROACETONE//2 2 BISTRIFLUOROMETHYL 1 3 DIOXOLAN 4 ONES//CITRAMALIC ACID |
| 9 | 0.0000086289 | CHIRAL IONIC LIQUIDS//CHIRAL SOLVENTS//CHIRAL CATIONS |
| 10 | 0.0000082304 | NOSIHEPTIDE//THIOPEPTIDES//NOCATHIACIN I |